ESMO Breast Cancer 2024 Exhibition aims to deliver a comprehensive overview of new data and to make sure it has a clear roadmap to the clinic, so get ready for a comprehensive and in-depth coverage of recent findings in the breast cancer field.
This is an important occasion to promote the value of your products and services both in an onsite and online setting.
Download the ESMO Breast Cancer 2024 Onsite Exhibition Manual
Download the ESMO Breast Cancer 2024 Virtual Exhibition Manual
Download the ESMO Breast Cancer 2024 Floorplan
Contacts
Onsite Exhibition Support
MAW (Medizinische Ausstellungs- und Werbegesellschaft)
International Exhibitions & Advertising
Freyung 6
1010 Vienna, Austria
E-mail: maw@media.co.at
Online Exhibition Support
ESMO Breast 2024 Secretariat
ESMO Head Office
E-mail: breast@esmo.org
Official Italian agency for AIFA procedure
AIFA rules are mandatory only for Italian Pharmaceutical Companies that will attend a congress abroad.
Any pharmaceutical company supporting or participating in a congress, is subjected to an authorisation by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124). The request of authorisation must be submitted within 60 days before the starting date of the event.
ESMO advises pharmaceutical companies to contact the Official Agency:
AIM Group International – AIM Education S.r.l.
Contact: Cristina Ghidoli
Via G. Ripamonti, 129
20141 Milan – Italy
Tel.: +39 02 56601 1
Fax.: +39 02 70048585
E-mail: aifa@aimgroup.eu